Correlation Between Inhibrx and Easton Pharmaceutica
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Easton Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Easton Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Easton Pharmaceutica, you can compare the effects of market volatilities on Inhibrx and Easton Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Easton Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Easton Pharmaceutica.
Diversification Opportunities for Inhibrx and Easton Pharmaceutica
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inhibrx and Easton is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Easton Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Easton Pharmaceutica and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Easton Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Easton Pharmaceutica has no effect on the direction of Inhibrx i.e., Inhibrx and Easton Pharmaceutica go up and down completely randomly.
Pair Corralation between Inhibrx and Easton Pharmaceutica
If you would invest 1,356 in Inhibrx on September 30, 2024 and sell it today you would earn a total of 145.00 from holding Inhibrx or generate 10.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Easton Pharmaceutica
Performance |
Timeline |
Inhibrx |
Easton Pharmaceutica |
Inhibrx and Easton Pharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Easton Pharmaceutica
The main advantage of trading using opposite Inhibrx and Easton Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Easton Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easton Pharmaceutica will offset losses from the drop in Easton Pharmaceutica's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Easton Pharmaceutica vs. Oric Pharmaceuticals | Easton Pharmaceutica vs. Lyra Therapeutics | Easton Pharmaceutica vs. Inhibrx | Easton Pharmaceutica vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |